Bronwen E Shaw


Ontology type: schema:Person     


Person Info

NAME

Bronwen E

SURNAME

Shaw

Publications in SciGraph latest 50 shown

  • 2019-03 Motives for joining an unrelated HSC donor registry: description, categorization, and association with donor availability in BONE MARROW TRANSPLANTATION
  • 2019-02-27 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2019-02 Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective? in CURRENT HEMATOLOGIC MALIGNANCY REPORTS
  • 2018-12-07 Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2018-10-03 Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation in BONE MARROW TRANSPLANTATION
  • 2018-10 Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2018-09 Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective in BONE MARROW TRANSPLANTATION
  • 2018-08 Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2018-06-05 EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment in BONE MARROW TRANSPLANTATION
  • 2018-05-24 Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection in BONE MARROW TRANSPLANTATION
  • 2018-05 Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2017-09 Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2017-09 Parent versus child donor perceptions of the bone marrow donation experience in BONE MARROW TRANSPLANTATION
  • 2017-06 Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes in BONE MARROW TRANSPLANTATION
  • 2017-05 Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants in BONE MARROW TRANSPLANTATION
  • 2017-05 Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2017-02 Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT in BONE MARROW TRANSPLANTATION
  • 2016-12 Variations in practice in UK transplant centers: results of a related donor care survey in BONE MARROW TRANSPLANTATION
  • 2016-12 Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections in BONE MARROW TRANSPLANTATION
  • 2016-09 Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN in BONE MARROW TRANSPLANTATION
  • 2016-07 Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned in BONE MARROW TRANSPLANTATION
  • 2016-02 Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening in BONE MARROW TRANSPLANTATION
  • 2016-01 Survival of patients who develop solid tumors following hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2015-12 Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients in THROMBOSIS JOURNAL
  • 2015-08 Secondary solid cancer screening following hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2015-05 Related hematopoietic cell donor care: is there a role for unrelated donor registries? in BONE MARROW TRANSPLANTATION
  • 2015-03 A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies in BONE MARROW TRANSPLANTATION
  • 2015-02 Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation in BONE MARROW TRANSPLANTATION
  • 2015-02 The impact of improved JACIE standards on the care of related BM and PBSC donors in BONE MARROW TRANSPLANTATION
  • 2015-01 A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent in BONE MARROW TRANSPLANTATION
  • 2015-01 Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study in BONE MARROW TRANSPLANTATION
  • 2014-10 Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature in BONE MARROW TRANSPLANTATION
  • 2014-09 Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1 in BONE MARROW TRANSPLANTATION
  • 2014-07 Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee in BONE MARROW TRANSPLANTATION
  • 2014-06 A review of the haematopoietic stem cell donation experience: is there room for improvement? in BONE MARROW TRANSPLANTATION
  • 2014-05 Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD in BONE MARROW TRANSPLANTATION
  • 2014-05 Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML in BONE MARROW TRANSPLANTATION
  • 2014-04 Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage in BONE MARROW TRANSPLANTATION
  • 2014-02 EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era in BONE MARROW TRANSPLANTATION
  • 2013-11 Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation in BONE MARROW TRANSPLANTATION
  • 2013-11 Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice in BONE MARROW TRANSPLANTATION
  • 2013-10 Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study in BONE MARROW TRANSPLANTATION
  • 2013-07 Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study in BONE MARROW TRANSPLANTATION
  • 2013-02 Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT) in BONE MARROW TRANSPLANTATION
  • 2013-02 Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision in BONE MARROW TRANSPLANTATION
  • 2012-08 A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer in IMMUNOGENETICS
  • 2012-06 Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD in BONE MARROW TRANSPLANTATION
  • 2011-11 WMDA guidelines for subsequent donations following initial BM or PBSCs in BONE MARROW TRANSPLANTATION
  • 2011-01 Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data in BONE MARROW TRANSPLANTATION
  • 2011-01 Unrelated hematopoietic stem cell donors as research subjects in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.30760.32", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.426108.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.83440.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240404.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5072.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.426412.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412639.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415598.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.18886.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412920.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415100.1", 
            "type": "Organization"
          }
        ], 
        "familyName": "Shaw", 
        "givenName": "Bronwen E", 
        "id": "sg:person.0727054455.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727054455.03"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:51", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_580.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0727054455.03'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0727054455.03'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0727054455.03'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0727054455.03'


     

    This table displays all metadata directly associated to this object as RDF triples.

    38 TRIPLES      10 PREDICATES      22 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0727054455.03 schema:affiliation N4d88c987f14747a0adc8dc97c563fae8
    2 https://www.grid.ac/institutes/grid.18886.3f
    3 https://www.grid.ac/institutes/grid.240404.6
    4 https://www.grid.ac/institutes/grid.412639.b
    5 https://www.grid.ac/institutes/grid.412920.c
    6 https://www.grid.ac/institutes/grid.415100.1
    7 https://www.grid.ac/institutes/grid.415598.4
    8 https://www.grid.ac/institutes/grid.424926.f
    9 https://www.grid.ac/institutes/grid.426108.9
    10 https://www.grid.ac/institutes/grid.426412.7
    11 https://www.grid.ac/institutes/grid.5072.0
    12 https://www.grid.ac/institutes/grid.83440.3b
    13 schema:familyName Shaw
    14 schema:givenName Bronwen E
    15 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727054455.03
    16 schema:sdDatePublished 2019-03-07T14:51
    17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    18 schema:sdPublisher N6d30aec5b2a1418a851d7dc00225604d
    19 sgo:license sg:explorer/license/
    20 sgo:sdDataset persons
    21 rdf:type schema:Person
    22 N4d88c987f14747a0adc8dc97c563fae8 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 N6d30aec5b2a1418a851d7dc00225604d schema:name Springer Nature - SN SciGraph project
    26 rdf:type schema:Organization
    27 https://www.grid.ac/institutes/grid.18886.3f schema:Organization
    28 https://www.grid.ac/institutes/grid.240404.6 schema:Organization
    29 https://www.grid.ac/institutes/grid.30760.32 schema:Organization
    30 https://www.grid.ac/institutes/grid.412639.b schema:Organization
    31 https://www.grid.ac/institutes/grid.412920.c schema:Organization
    32 https://www.grid.ac/institutes/grid.415100.1 schema:Organization
    33 https://www.grid.ac/institutes/grid.415598.4 schema:Organization
    34 https://www.grid.ac/institutes/grid.424926.f schema:Organization
    35 https://www.grid.ac/institutes/grid.426108.9 schema:Organization
    36 https://www.grid.ac/institutes/grid.426412.7 schema:Organization
    37 https://www.grid.ac/institutes/grid.5072.0 schema:Organization
    38 https://www.grid.ac/institutes/grid.83440.3b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...